Anzu Partners is an investment firm that invests in industrial and life science technology companies.
Business Model:
Revenue: $0
Employees: 0-0
Address: 1399 New York Ave NW Ste 601
City: Washington
State: district of columbia
Zip: 20005
Country: US
Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu&s;s portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.
Contact Phone:
+12027425870
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2021 | ImmunoSCAPE | Venture Round | 14M |
2/2021 | Excision BioTherapeutics | Series A | - |
9/2016 | Pivotal Systems | Series D | - |
3/2016 | Pivotal Systems | Convertible Note | - |
2/2020 | NTxBio | Series A | 13M |
1/2017 | Banyan Biomarkers | Venture Round | 7M |
7/2017 | MultiMechanics | Seed Round | 1.9M |
5/2019 | Amastan Technologies | Series B | 0 |
4/2022 | e-Zinc | Series A | 0 |
5/2021 | Liquid Instruments | Convertible Note | 13.7M |
6/2022 | Arduino | Series B | 0 |
6/2017 | SLIPS Technologies | Series B | 5.7M |
5/2015 | Lightship Works | Seed Round | - |
4/2022 | Codetta Biosciences | Series A | 15M |
8/2021 | InterVenn | Series C | 0 |
3/2023 | TeraPore Technologies | Venture Round | 0 |
3/2018 | TeraPore Technologies | Series A | 6M |
12/2014 | Pivotal Systems | Venture Round | - |
11/2020 | InterVenn | Series B | 0 |
12/2022 | EnCharge AI | Series A | 0 |
2/2021 | Excision BioTherapeutics | Venture Round | 0 |
2/2018 | NUBURU | Venture Round | 15.5M |
4/2019 | Zeteo Tech | Grant | 6.5M |
1/2020 | BioSkryb | Seed Round | 11.5M |
4/2022 | South 8 Technologies | Series A | 12M |
8/2020 | ImmunoSCAPE | Venture Round | 11M |
12/2020 | NUBURU | Series B | 20M |
7/2021 | Niron Magnetics | Venture Round | 21.3M |
12/2016 | Niron Magnetics | Series B | 5M |
10/2015 | Axsun Technologies | Private Equity Round | - |
7/2020 | Weavr Health | Series B | 4.5M |
5/2018 | Voltaiq | Series A | 6.6M |
1/2022 | NUBURU | Private Equity Round | 5.6M |
6/2020 | BioFlyte | Seed Round | 1.3M |
4/2022 | BioFlyte | Series A | 6.1M |
4/2022 | CytoTronics | Seed | 9.3M |
10/2022 | AM Batteries | Series A | 0 |
9/2020 | Aspinity | Series A | 0 |
10/2022 | OTI Lumionics | Series B | 0 |
12/2020 | Azumo | Venture Round | 9M |
2/2023 | Opscura | Series A | 0 |
6/2015 | Osperity Inc. | Series A | 971k |
9/2021 | 6K | Series C | 0 |
5/2019 | 6K | Series B | 0 |
1/2020 | GelSight | Series B | 10M |
11/2022 | MedCrypt | Series B | 0 |
11/2017 | NanoCellect Biomedical | Series B | 0 |
6/2016 | TeraPore Technologies | Seed Round | - |
5/2022 | Azumo | Venture Round | 0 |
12/2019 | Sofregen Medical | Series B | 8M |
8/2020 | OTI Lumionics | Venture Round | - |
11/2021 | XENDEE Corporation | Equity | 8M |
8/2021 | NanoCellect Biomedical | Series D | 0 |
8/2019 | Weavr Health | Series A | 17.5M |
5/2021 | Liquid Instruments | Series B | 13.7M |
1/2019 | Liquid Instruments | Series A | 8.2M |
11/2016 | OTI Lumionics | Series A | - |
10/2017 | 6K | Series B | 0 |
6/2022 | XENDEE Corporation | Series A | 0 |
10/2017 | Amastan Technologies | Series B | 0 |
9/2022 | ImmunoScape | Venture Round | 14M |
6/2022 | XENDEE Corporation | Series A | 0 |
6/2022 | Arduino | Series B | 0 |
5/2022 | Azumo | Venture Round | 0 |
4/2022 | CytoTronics | Seed Round | 0 |
4/2022 | South 8 Technologies | Series A | 0 |
4/2022 | BioFlyte | Series A | 0 |
4/2022 | e-Zinc | Series A | 0 |
4/2022 | Codetta Biosciences | Series A | 0 |
1/2022 | NUBURU | Private Equity Round | 0 |
11/2021 | XENDEE Corporation | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|